NATUS MEDICAL INC (NTUS) Forecast, Price Target & Analyst Ratings

NASDAQ:NTUSUS6390501038

Current stock price

32.96 USD
+0.03 (+0.09%)
At close:
32.96 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NATUS MEDICAL INC (NTUS).

Forecast Snapshot

Consensus Price Target

Price Target
$0.00
-100.00% Downside

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 4, 2022
Period
Q2 / 2022
EPS Estimate
$0.33
Revenue Estimate
122.808M

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$0.00
Upside
-100.00%
From current price of $32.96 to mean target of $0.00, Based on 6 analyst forecasts
Low
$0.00
Median
$0.00
High
$0.00

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

Analyst Ratings & History

Current Analyst Ratings

NTUS Current Analyst RatingNTUS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

NTUS Historical Analyst RatingsNTUS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 1 2 3 4 5

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
NTUS was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about NTUS.
In the previous month the buy percentage consensus was at a similar level.
NTUS was analyzed by 6 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 4, 2022
Period
Q2 / 2022
EPS Estimate
$0.33
Revenue Estimate
122.808M
Revenue Q2Q
5.89%
EPS Q2Q
12.55%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

NTUS is expected to report earnings on 8/4/2022. The consensus EPS estimate for the next earnings is 0.33 USD and the consensus revenue estimate is 122.81M USD.

Full Analyst Estimates 2022 - 2025

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
NTUS revenue by date.NTUS revenue by date.
495.2M
-6.72%
415.7M
-16.05%
473.44M
13.89%
504.9M
6.64%
527.544M
4.48%
541.975M
2.74%
567.937M
4.79%
EBITDA
YoY % growth
NTUS ebitda by date.NTUS ebitda by date.
59.72M
28.54%
18.12M
-69.66%
57.47M
217.16%
N/AN/AN/AN/A
EBIT
YoY % growth
NTUS ebit by date.NTUS ebit by date.
29M
130.16%
-10M
-134.48%
29.38M
393.80%
66.912M
127.75%
73.338M
9.60%
179.75M
145.10%
449.375M
150.00%
Operating Margin
NTUS operating margin by date.NTUS operating margin by date.
5.86%-2.41%6.21%13.25%13.90%33.17%79.12%
EPS
YoY % growth
NTUS eps by date.NTUS eps by date.
1.25
-11.97%
0.39
-68.80%
1.20
207.69%
1.47
22.40%
1.60
9.03%
1.84
14.83%
2.15
17.12%

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 22 Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth
0.33
12.55%
0.38
34.79%
0.50
6.34%
0.35
57.64%
0.36
9.37%
0.40
5.41%
0.50
Revenue
Q2Q % growth
122.808M
5.89%
126.174M
10.80%
137.904M
7.18%
124.134M
3.63%
128.724M
4.82%
130.458M
3.40%
144.126M
4.51%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
14.892M
142.94%
17.136M
123.13%
22.44M
63.44%
15.81M
153.77%
16.32M
9.59%
18.156M
5.95%
23.052M
2.73%

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NTUS Yearly Revenue VS EstimatesNTUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
NTUS Yearly EPS VS EstimatesNTUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
15.29%
EPS Next 5 Year
15.74%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
4.10%
Revenue Next 5 Year
4.27%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

NATUS MEDICAL INC / NTUS Forecast FAQ

What is the next earnings date for NTUS stock?

NATUS MEDICAL INC (NTUS) will report earnings on 2022-08-04, after the market close.

What are the consensus estimates for NATUS MEDICAL INC (NTUS) next earnings?

The consensus EPS estimate for the next earnings of NATUS MEDICAL INC (NTUS) is 0.33 USD and the consensus revenue estimate is 122.81M USD.

What is the expected long term growth rate for NTUS stock?

The expected long term growth rate for NATUS MEDICAL INC (NTUS) is 4.1%.